A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

Abstract

Objective To investigate the role of clinical pharmacists in managing iron deficiency anaemia patients. Methods A prospective parallel randomised controlled trial conducted in an outpatient clinic enrolled adult iron deficiency anaemia patients. Patients were randomised into either an intervention or a control group. Patients in the intervention group were followed closely by a clinical pharmacist who offered pharmaceutical care services and worked closely with physicians to manage iron deficiency anaemia. Patients in the control group received the usual medical care.

A systematic review on the impact of pharmacist‐provided services on patients’ health outcomes in Arab countries

“…47,49 One retrospective cohort study by Elewa et al also found that a high percentage of patients in the intervention group experienced a therapeutic INR compared to the control group. 48 The impact of pharmacist-provided care was also recognized in improving clinical outcomes in studies that focused on patients with dyslipidaemia, 55 heart failure, 56 polycystic ovary syndrome, 57 anaemia, 60 metabolic syndrome 63 and hepatitis C. 64 Moreover, this positive impact was also demonstrated in studies that did not include patients with specific medical conditions, but focused on patients with polypharmacy or multiple chronic conditions. 58,61 Other studies reported a positive effect of pharmacist care on hospitalization, 46,54,58,65 sickness days 46 and emergency department visits.…”

“…Most of the studies involved patients with specific medical conditions, including diabetes (n = 8), [36][37][38][39][40][41][42][43] asthma (n = 4), [44][45][46]69 hypertension (n = 4), [50][51][52][53] receiving warfarin therapy (n = 4) [47][48][49]71 and other medical conditions (n = 9). [55][56][57]59,60,[62][63][64]68 The remaining studies (n = 6) 58,61,[65][66][67]70 included generic characteristics such as patients for discharge 58 or patients receiving polypharmacy. 61 The pharmacist's intervention involved mainly one or more of the following, MTM (n = 32), [60][61][62][63][64][66][67][68][69] pharmacist-led counselling or education (n = 29) [36][37...…”

“…[55][56][57]59,60,[62][63][64]68 The remaining studies (n = 6) 58,61,[65][66][67]70 included generic characteristics such as patients for discharge 58 or patients receiving polypharmacy. 61 The pharmacist's intervention involved mainly one or more of the following, MTM (n = 32), [60][61][62][63][64][66][67][68][69] pharmacist-led counselling or education (n = 29) [36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][55][56][57]60,62,63,[65]…”

Effect of anemia on HbA1c level in subjects with normal glucose tolerance.

“…2 All age groups, more commonly preschool-aged children and pregnant women are affected by anemia. 3 Anemia, an unrecognized complication of diabetes mellitus contributes to the pathogenesis and progression of various problems. 4 The most common cause of anemia is Iron deficiency anemia (IDA).…”

Evaluation of the clinical pharmacist's role in educating women about the benefits and risks of combined oral contraceptive pills in Jordan

“…A number of studies investigated the role of pharmacists in educating patients in various disease states. [7][8][9][10] In Australia, a prospective study was conducted to evaluate the role of pharmacists in asthma management. Pharmacists' responsibilities included patient education.…”